Interest in genetic testing among affected men from hereditary prostate cancer families and their unaffected male relatives
- PMID: 19346959
- PMCID: PMC2683189
- DOI: 10.1097/GIM.0b013e31819b2425
Interest in genetic testing among affected men from hereditary prostate cancer families and their unaffected male relatives
Abstract
Purpose: The objective of this study was to evaluate potential sociodemographic, medical, psychosocial, and behavioral correlates of interest in genetic testing in men from hereditary prostate cancer families.
Methods: Family members affected with prostate cancer (n = 559) and their unaffected male relatives (n = 370) completed a mailed survey. Multivariable logistic regression models were used to examine the association between potential correlates and interest in genetic testing for prostate cancer.
Results: Forty-five percent of affected and 56% of unaffected men reported that they definitely would take a genetic test for prostate cancer. More affected men reported high levels of familiarity with genetic testing than unaffected men (46 vs. 25%). There were several variables that were significantly correlated with interest in either affected or unaffected men, but only age and familiarity with genetics were significant in both groups. After controlling for confounding variables, only familiarity remained a significant correlate in both groups.
Conclusions: The contrast between low levels of familiarity with genetics and high test interest among unaffected men highlights the need for increased educational efforts targeting hereditary prostate cancer families. Overall, results illuminated several novel characteristics of men from hereditary prostate cancer families that should be considered when developing future informed consent procedures or educational materials for prostate cancer genetic testing.
Similar articles
-
Interest in, willingness-to-pay for and willingness-to-recommend genetic testing for prostate cancer among affected men after radical prostatectomy.Fam Cancer. 2019 Apr;18(2):221-230. doi: 10.1007/s10689-018-0101-7. Fam Cancer. 2019. PMID: 30229510
-
Genetic testing for prostate cancer. Willingness and predictors of interest.Cancer Pract. 2000 Mar-Apr;8(2):82-6. doi: 10.1046/j.1523-5394.2000.82006.x. Cancer Pract. 2000. PMID: 11898181
-
Risk perception, screening practice and interest in genetic testing among unaffected men in families with hereditary prostate cancer.Eur J Cancer. 2000 Jan;36(2):235-41. doi: 10.1016/s0959-8049(99)00272-5. Eur J Cancer. 2000. PMID: 10741283
-
Genomics of Prostate Cancer: What Nurses Need to Know.Semin Oncol Nurs. 2019 Feb;35(1):79-92. doi: 10.1016/j.soncn.2018.12.003. Epub 2019 Jan 18. Semin Oncol Nurs. 2019. PMID: 30665733 Review.
-
Genetic testing in prostate cancer management: Considerations informing primary care.CA Cancer J Clin. 2022 Jul;72(4):360-371. doi: 10.3322/caac.21720. Epub 2022 Feb 24. CA Cancer J Clin. 2022. PMID: 35201622 Review.
Cited by
-
Men seeking counselling in a Breast Cancer Risk Evaluation Clinic.Ecancermedicalscience. 2018 Jan 30;12:804. doi: 10.3332/ecancer.2018.804. eCollection 2018. Ecancermedicalscience. 2018. PMID: 29456621 Free PMC article.
-
Engaging Men With BRCA-Related Cancer Risks: Practical Advice for BRCA Risk Management From Male Stakeholders.Am J Mens Health. 2020 May-Jun;14(3):1557988320924932. doi: 10.1177/1557988320924932. Am J Mens Health. 2020. PMID: 32449425 Free PMC article.
-
Male awareness of prostate cancer risk remains poor in relatives of women with germline variants in DNA-repair genes.BJUI Compass. 2023 Jun 21;4(6):738-745. doi: 10.1002/bco2.252. eCollection 2023 Nov. BJUI Compass. 2023. PMID: 37818031 Free PMC article.
-
Interest in, willingness-to-pay for and willingness-to-recommend genetic testing for prostate cancer among affected men after radical prostatectomy.Fam Cancer. 2019 Apr;18(2):221-230. doi: 10.1007/s10689-018-0101-7. Fam Cancer. 2019. PMID: 30229510
-
Employees' Views and Ethical, Legal, and Social Implications Assessment of Voluntary Workplace Genomic Testing.Front Genet. 2021 Mar 17;12:643304. doi: 10.3389/fgene.2021.643304. eCollection 2021. Front Genet. 2021. PMID: 33815477 Free PMC article.
References
-
- Jemal A, Siegel R, Ward E, et al. Cancer statistics, 2008. CA Cancer J Clin. 2008;58:71–96. - PubMed
-
- Bruner DW, Moore D, Parlanti A, Dorgan J, Engstrom P. Relative risk of prostate cancer for men with affected relatives: systematic review and meta-analysis. Int J Cancer. 2003;107:797–803. - PubMed
-
- Zeegers MPJA, Ostrer H. Empiric risk of prostate carcinoma for relatives of patients with prostate carcinoma: a meta-analysis. Cancer. 2003;97:1894–903. - PubMed
-
- Langeberg WJ, Isaacs WB, Stanford JL. Genetic etiology of hereditary prostate cancer. Front Biosci. 2007;12:4101–10. - PubMed
-
- Amundadottir LT, Sulem P, Gudmundsson J, et al. A common variant associated with prostate cancer in European and African populations. Nat Genet. 2006;38:652–8. - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical